
CAS: 1773489-72-7

Benzoic acid, 4-[[[(8-chloro-1,4-dihydro-1-methyl[1]benzopyrano[4,3-c]pyrazol-3-yl)carbonyl](phenylmethyl)amino]methyl]-
CAS:1773489-72-7
Formula:
C27H22ClN3O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
487.9343
Ref: IN-DA00258Y
5mg | 65.00 € | ||
10mg | 97.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025

4-((N-Benzyl-8-Chloro-1-Methyl-1,4-Dihydrochromeno[4,3-c]Pyrazole-3-Carboxamido)Methyl)Benzoic Acid
CAS:1773489-72-7
Purity:
95%
Molecular weight:
487.93g/mol
Ref: 54-OR1023979
1g | 1,529.00 € | ||
100mg | 273.00 € | ||
250mg | 454.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025

Ref: 54-BUP04339
25mg | 534.00 € | ||
50mg | 799.00 € | ||
100mg | 1,106.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025

Nidufexor
CAS:1773489-72-7
Nidufexor is an agonist for the farnesoid X receptor (FXR).
Formula:
C27H22ClN3O4
Purity:
98.67%
Color and Shape:
Solid
Molecular weight:
487.93
Ref: TM-T7886
1mg | 56.00 € | ||
5mg | 119.00 € | ||
10mg | 188.00 € | ||
25mg | 358.00 € | ||
50mg | 535.00 € | ||
100mg | 753.00 € | ||
1mL*10mM (DMSO) | 131.00 € |
Estimated delivery in United States, on Wednesday 23 Apr 2025

Nidufexor
CAS:1773489-72-7
Nidufexor is a compound with diverse characteristics, including its structure and therapeutic potential. It has …
Formula:
C27H22ClN3O4
Purity:
Min. 95%
Molecular weight:
487.93 g/mol
Ref: 3D-YVC48972
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |